Aptevo Therapeutics Inc.

APVO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
S-8 Jul 24, 2026 S-8
8-K Jun 30, 2026 8-K
SCHEDULE 13G Jun 22, 2026
3 Jun 22, 2026 PRIMARY DOCUMENT
3 May 28, 2026 3
8-K May 27, 2026 8-K
10-Q May 13, 2026 10-Q
8-K May 13, 2026 8-K
8-K May 6, 2026 8-K
10-K Mar 26, 2026 10-K
8-K Mar 26, 2026 8-K
8-K Mar 11, 2026 8-K
8-K Feb 19, 2026 8-K
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 17, 2026
8-K Feb 3, 2026 8-K
EFFECT Jan 30, 2026
424B4 Jan 30, 2026 424B4
CORRESP Jan 29, 2026
UPLOAD Jan 29, 2026
S-1 Jan 28, 2026 S-1
DEF 14A Jan 26, 2026 DEF 14A
PRE 14A Jan 16, 2026 PRE 14A
8-K Jan 9, 2026 8-K
8-K Dec 29, 2025 8-K
← Newer Page 2 of 30 · 729 filings Older →